Birdwatch Note
2024-04-09 08:18:24 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
接種と急性腎不全・腎障害は世界中で調査済で下記の4研究が百~数百万人程の接種者で対照と比べた新規医療記録のリスク増加の検出ができずとしています。 https://www.nejm.org/doi/full/10.1056/nejmoa2110475 https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018 https://link.springer.com/article/10.1007/s40264-023-01332-1 https://www.sciencedirect.com/science/article/pii/S0085253822006974 一時学会より注意喚起がされたIgA腎症に関しては腎臓学会自身が大半は一過性とし↓ https://jsn.or.jp/medic/covid19/notice/content-30.php 重篤な腎障害は見られず↓ https://twitter.com/jsnorjp/status/1506514395312328705 ています。 またIgA腎症の年度末の登録済難病患者数の推移は下記の通りでこの話の21年度はむしろ新規登録が少ないです 18年3月7796 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000031761451&fileKind=1 19年3月8696 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000031873765&fileKind=1 20年3月10074 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000032045204&fileKind=1 21年3月12669 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000032155828&fileKind=1 22年3月12447 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000040002898&fileKind=1 23年3月13354 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000040112009&fileKind=1
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1777601596672659634
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1777612009548525791
- noteId - 1777612009548525791
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1712650704168
- tweetId - 1777601596672659634
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 接種と急性腎不全・腎障害は世界中で調査済で下記の4研究が百~数百万人程の接種者で対照と比べた新規医療記録のリスク増加の検出ができずとしています。 https://www.nejm.org/doi/full/10.1056/nejmoa2110475 https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018 https://link.springer.com/article/10.1007/s40264-023-01332-1 https://www.sciencedirect.com/science/article/pii/S0085253822006974 一時学会より注意喚起がされたIgA腎症に関しては腎臓学会自身が大半は一過性とし↓ https://jsn.or.jp/medic/covid19/notice/content-30.php 重篤な腎障害は見られず↓ https://twitter.com/jsnorjp/status/1506514395312328705 ています。 またIgA腎症の年度末の登録済難病患者数の推移は下記の通りでこの話の21年度はむしろ新規登録が少ないです 18年3月7796 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000031761451&fileKind=1 19年3月8696 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000031873765&fileKind=1 20年3月10074 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000032045204&fileKind=1 21年3月12669 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000032155828&fileKind=1 22年3月12447 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000040002898&fileKind=1 23年3月13354 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000040112009&fileKind=1
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-09 08:18:24 UTC (1712650704168) |
2024-04-09 14:39:58 UTC (1712673598584) |
CURRENTLY_RATED_HELPFUL | 2024-04-10 03:59:53 UTC (1712721593071) |
CURRENTLY_RATED_HELPFUL | 2024-04-09 14:39:58 UTC (1712673598584) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-09 20:16:19 -0500 | Rating Details | |
2024-04-09 19:42:14 -0500 | Rating Details | |
2024-04-09 19:04:10 -0500 | Rating Details | |
2024-04-09 18:29:28 -0500 | Rating Details | |
2024-04-09 18:06:44 -0500 | Rating Details | |
2024-04-09 17:00:46 -0500 | Rating Details | |
2024-04-09 15:37:43 -0500 | Rating Details | |
2024-04-09 14:23:37 -0500 | Rating Details | |
2024-04-09 13:31:17 -0500 | Rating Details | |
2024-04-09 11:00:58 -0500 | Rating Details | |
2024-04-09 10:31:51 -0500 | Rating Details | |
2024-04-09 10:15:24 -0500 | Rating Details | |
2024-04-09 10:01:00 -0500 | Rating Details | |
2024-04-09 08:48:00 -0500 | Rating Details | |
2024-04-09 08:47:00 -0500 | Rating Details | |
2024-04-09 07:58:21 -0500 | Rating Details | |
2024-04-09 07:56:28 -0500 | Rating Details | |
2024-04-09 07:33:55 -0500 | Rating Details | |
2024-04-09 07:04:03 -0500 | Rating Details | |
2024-04-09 06:56:14 -0500 | Rating Details | |
2024-04-09 06:49:26 -0500 | Rating Details | |
2024-04-09 05:59:50 -0500 | Rating Details | |
2024-04-09 05:43:11 -0500 | Rating Details | |
2024-04-09 04:42:21 -0500 | Rating Details | |
2024-04-09 04:39:38 -0500 | Rating Details | |
2024-04-09 04:13:18 -0500 | Rating Details | |
2024-04-09 04:05:10 -0500 | Rating Details | |
2024-04-09 04:02:18 -0500 | Rating Details | |
2024-04-09 03:50:12 -0500 | Rating Details | |
2024-04-09 03:32:06 -0500 | Rating Details | |
2024-04-09 03:31:02 -0500 | Rating Details | |
2024-04-09 03:26:41 -0500 | Rating Details | |
2024-04-09 03:24:07 -0500 | Rating Details | |
2024-04-10 00:49:11 -0500 | Rating Details | |
2024-04-09 21:37:05 -0500 | Rating Details | |
2024-04-11 07:15:48 -0500 | Rating Details | |
2024-04-11 00:08:35 -0500 | Rating Details | |
2024-04-13 08:27:58 -0500 | Rating Details | |
2024-04-15 16:47:16 -0500 | Rating Details | |
2024-04-16 02:41:22 -0500 | Rating Details | |
2024-04-16 02:27:07 -0500 | Rating Details | |
2024-04-17 18:26:18 -0500 | Rating Details | |
2024-04-09 20:13:28 -0500 | Rating Details | |
2024-04-09 17:34:38 -0500 | Rating Details | |
2024-04-09 17:29:49 -0500 | Rating Details | |
2024-04-09 16:36:15 -0500 | Rating Details | |
2024-04-09 12:25:55 -0500 | Rating Details | |
2024-04-09 12:20:14 -0500 | Rating Details | |
2024-04-09 11:17:54 -0500 | Rating Details | |
2024-04-09 10:14:26 -0500 | Rating Details | |
2024-04-09 08:32:13 -0500 | Rating Details | |
2024-04-09 08:28:33 -0500 | Rating Details | |
2024-04-09 08:28:15 -0500 | Rating Details | |
2024-04-09 08:02:08 -0500 | Rating Details | |
2024-04-09 07:19:36 -0500 | Rating Details | |
2024-04-09 05:26:16 -0500 | Rating Details | |
2024-04-09 05:22:17 -0500 | Rating Details | |
2024-04-09 05:20:28 -0500 | Rating Details | |
2024-04-09 05:10:38 -0500 | Rating Details | |
2024-04-09 05:04:20 -0500 | Rating Details | |
2024-04-09 04:38:32 -0500 | Rating Details | |
2024-04-09 04:17:43 -0500 | Rating Details | |
2024-04-09 04:14:45 -0500 | Rating Details | |
2024-04-09 04:14:11 -0500 | Rating Details | |
2024-04-09 03:54:31 -0500 | Rating Details | |
2024-04-09 03:53:31 -0500 | Rating Details | |
2024-04-09 03:40:46 -0500 | Rating Details | |
2024-04-09 03:36:11 -0500 | Rating Details | |
2024-04-09 03:26:56 -0500 | Rating Details | |
2024-04-09 11:22:45 -0500 | Rating Details | |
2024-04-09 15:53:22 -0500 | Rating Details | |
2024-04-09 11:24:40 -0500 | Rating Details | |
2024-04-17 18:16:11 -0500 | Rating Details | |
2024-04-16 02:58:53 -0500 | Rating Details | |
2024-04-16 02:26:33 -0500 | Rating Details | |
2024-04-11 06:51:45 -0500 | Rating Details | |
2024-04-10 08:01:50 -0500 | Rating Details | |
2024-04-10 04:56:27 -0500 | Rating Details | |
2024-04-10 04:25:27 -0500 | Rating Details | |
2024-04-09 23:46:05 -0500 | Rating Details | |
2024-04-09 23:41:43 -0500 | Rating Details | |
2024-04-09 23:18:56 -0500 | Rating Details | |
2024-04-09 19:41:19 -0500 | Rating Details | |
2024-04-09 15:39:05 -0500 | Rating Details | |
2024-04-09 14:46:34 -0500 | Rating Details | |
2024-04-09 14:40:35 -0500 | Rating Details | |
2024-04-09 12:09:05 -0500 | Rating Details | |
2024-04-09 11:19:50 -0500 | Rating Details | |
2024-04-09 10:26:29 -0500 | Rating Details | |
2024-04-09 10:24:45 -0500 | Rating Details | |
2024-04-09 10:14:54 -0500 | Rating Details | |
2024-04-09 08:24:45 -0500 | Rating Details | |
2024-04-09 08:06:11 -0500 | Rating Details | |
2024-04-09 08:05:21 -0500 | Rating Details | |
2024-04-09 07:48:10 -0500 | Rating Details | |
2024-04-09 07:25:20 -0500 | Rating Details | |
2024-04-09 07:00:41 -0500 | Rating Details | |
2024-04-09 04:52:13 -0500 | Rating Details | |
2024-04-09 04:49:11 -0500 | Rating Details | |
2024-04-09 04:40:48 -0500 | Rating Details | |
2024-04-09 04:35:05 -0500 | Rating Details | |
2024-04-09 04:28:37 -0500 | Rating Details | |
2024-04-09 04:09:42 -0500 | Rating Details | |
2024-04-09 04:02:12 -0500 | Rating Details | |
2024-04-09 04:00:44 -0500 | Rating Details | |
2024-04-09 03:53:03 -0500 | Rating Details | |
2024-04-09 03:51:03 -0500 | Rating Details | |
2024-04-09 03:48:25 -0500 | Rating Details | |
2024-04-09 03:43:06 -0500 | Rating Details | |
2024-04-09 03:39:05 -0500 | Rating Details | |
2024-04-09 03:37:58 -0500 | Rating Details | |
2024-04-09 03:36:56 -0500 | Rating Details | |
2024-04-09 03:31:24 -0500 | Rating Details | |
2024-04-09 03:31:21 -0500 | Rating Details | |
2024-05-08 16:04:47 -0500 | Rating Details | |
2024-07-06 09:25:37 -0500 | Rating Details |